封面
市場調查報告書
商品編碼
1512678

全球乳酸菌益生菌市場 - 2024-2031

Global Lactobacillus Probiotic Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 213 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年,全球乳酸菌益生菌市場規模達27億美元,預計到2031年將達到49億美元,2024-2031年預測期間複合年成長率為8.9%。

市場對促進腸道健康的功能性食品和飲料的需求顯著增加。乳酸菌益生菌越來越融入優格、冰沙和膳食補充劑等產品中,滿足消費者對方便、促進健康的選擇的需求。持續的科學研究透過發現乳酸菌益生菌的新健康益處來推動市場,並推動消費者興趣和市場成長。

例如,2024 年3 月21 日,TrueNorth 推出了「Sensibiotics」品牌的尖端益生菌解決方案,以解決與敏感腸道和女性健康相關的問題,戰略重點是印度不斷擴大的腸道健康市場,預計將達到49.1 億美元,以及女性健康市場,預計收入為 9 億美元。這種創新配方將鼠李糖乳桿菌 GG (ATCC 53103)(被認為是全球研究最廣泛的益生菌菌株之一)與布拉酵母菌結合。

亞太市場的功能性食品和飲料產業正在經歷顯著成長。乳酸菌益生菌正被納入各種產品以及新穎的應用中,以滿足注重健康的消費者的需求。益生菌配方和輸送系統的創新正在增強區域市場。微膠囊化和其他技術的進步正在提高乳酸菌益生菌的穩定性和功效,使其對消費者更具吸引力。

動力學

人們越來越認知到益生菌的健康益處

人們對益生菌健康益處的認知不斷提高,正在推動全球乳酸菌益生菌市場的發展。隨著消費者越來越了解益生菌對消化健康、免疫功能和整體健康的正面影響,對乳酸菌益生菌的需求正在上升。大量科學研究、媒體報導和健康運動都強調了維持健康腸道微生物組的重要性,從而提高了人們的認知。

製造商正在開發各種乳酸菌益生菌產品,包括膳食補充劑、功能性食品和飲料,以滿足不斷成長的消費者需求。市場正在加大研發投入,以提高乳酸菌益生菌的功效和穩定性,進一步增強消費者信心和市場採用率。

例如,2023年9月7日,韓國hy(原名韓國養樂多)推出了膏霜類化妝品Leti 7714三重提拉抗衰老霜。該產品是該公司推出的第二款含有皮膚乳酸菌7714 的化妝品產品,皮膚乳酸菌7714 是一種培養乳酸菌的發酵衍生物,該產品已進軍化妝品市場,其產品由利用其專有乳酸菌的發酵成分製成。

擴大營養保健品產業

不斷擴大的營養保健品產業正在推動全球乳酸菌益生菌市場的發展。隨著消費者對增強健康產品的需求不斷成長,營養保健品產業不斷發展,乳酸菌益生菌市場正經歷顯著成長。營養保健品,包括膳食補充劑、功能性食品和飲料最終用戶,通常含有益生菌以增強其健康益處,從而增加了乳酸菌菌株的市場需求。

市場上營養保健品公司與研究機構之間的合作日益增加。這些合作關係旨在驗證乳酸菌益生菌的健康聲明,提高產品可信度和消費者信任度。因此,市場的特徵是有科學根據的乳酸菌益生菌產品不斷湧入,吸引了注重健康的消費者。

例如,2023年9月9日,SIG和AnaBio Technologies合作推出了世界上首款長保存期限益生菌優格,標誌著益生菌飲料和無菌包裝的重大進步。這項開創性的成就預示著一種新型產品類別的出現:採用無菌紙盒包裝和帶嘴袋包裝的益生菌飲料,無需冷藏即可延長保存期限。

發展中地區消費者意識缺乏

發展中地區消費者意識的缺乏正在限制全球乳酸菌益生菌市場。在這些地區,對益生菌健康益處的了解有限以及對其使用的誤解阻礙了市場的成長。儘管乳酸菌益生菌具有潛在的健康優勢,但市場在接觸和教育發展中地區的消費者方面面臨挑戰。

發展中地區的消費者不太可能尋找或信任這些產品,通常會優先考慮更傳統或熟悉的健康解決方案。因此,乳酸菌益生菌的市場滲透率仍然有限,影響了整體市場成長。市場參與者在行銷和分銷方面遇到困難。如果沒有消息靈通的消費者基礎,推廣乳酸菌益生菌產品的努力就會面臨重大障礙。

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 人們越來越認知到益生菌的健康益處
      • 擴大營養保健品產業
    • 限制
      • 發展中地區消費者意識缺乏
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章:COVID-19 分析

第 7 章:按形式

  • 液體
  • 粉末
  • 膠囊
  • 藥片
  • 其他

第 8 章:按配銷通路

  • 零售藥房
  • 醫院藥房
  • 超級市場和大賣場
  • 網路藥房
  • 其他

第 9 章:按申請

  • 食品和飲料最終用戶
  • 藥品
  • 膳食補充劑
  • 其他

第 10 章:最終用戶

  • 嬰兒
  • 孩子們
  • 成年人
  • 老年人

第 11 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 12 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章:公司簡介

  • Mitushi BioPharma
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Goerlich Pharma GmbH
  • Nutra Healthcare Private Limited
  • Fermentis Life Sciences
  • Unique Biotech
  • Culturelle Probiotic Canada
  • BJP Laboratories
  • ProbioFerm
  • Fido Pharma Pvt. Ltd.
  • Probiotics Australia

第 14 章:附錄

簡介目錄
Product Code: FB8527

Overview

Global Lactobacillus Probiotic Market reached US$ 2.7 billion in 2023 and is expected to reach US$ 4.9 billion by 2031, growing with a CAGR of 8.9% during the forecast period 2024-2031.

The market is witnessing a significant increase in demand for functional foods and beverages that promote gut health. Lactobacillus probiotics are increasingly incorporated into products like yogurts, smoothies, and dietary supplements, meeting consumer demand for convenient, health-boosting options. Ongoing scientific research drives the market by uncovering new health benefits of lactobacillus probiotics and propels consumer interest and market growth.

For instance, on March 21, 2024, TrueNorth introduced cutting-edge probiotic solutions under the brand name 'Sensibiotics' to address issues related to sensitive gut and feminine health, with a strategic focus on India's expanding gut health market, projected to reach $4.91 billion, and the feminine health market, projected at $0.9 billion in revenues. This innovative formulation combines lactobacillus rhamnosus GG (ATCC 53103), recognized as one of the most extensively researched probiotic strains globally, with Saccharomyces Boulardii.

The Asia-Pacific market is experiencing significant growth in the functional foods and beverages sector. Lactobacillus probiotics are being incorporated into various products, as well as novel applications, catering to health-conscious consumers. Innovations in probiotic formulations and delivery systems are enhancing the regional market. Advances in microencapsulation and other technologies are improving the stability and efficacy of lactobacillus probiotics, making them more appealing to consumers.

Dynamics

Growing Awareness about the Health Benefits of Probiotics

Growing awareness about the health benefits of probiotics is driving the global lactobacillus probiotic market. As consumers become increasingly informed about the positive impacts of probiotics on digestive health, immune function, and overall well-being, the demand for lactobacillus probiotics is rising. This heightened awareness is fueled by a plethora of scientific studies, media coverage, and health campaigns that emphasize the importance of maintaining a healthy gut microbiome.

Manufacturers are developing a wide range of lactobacillus probiotic products, including dietary supplements, functional foods, and beverages, to cater to the growing consumer demand. The market is witnessing increased investment in research and development to enhance the efficacy and stability of lactobacillus probiotics, further boosting consumer confidence and market adoption.

For instance, on September 7, 2023, South Korea's hy, previously known as Korea Yakult, introduced the Leti 7714 Triple Lift-up Anti-aging Cream, a cream-type cosmetic. This product is the company's second cosmetic offering that incorporates skin lactobacillus 7714, a fermented derivative of cultured lactic acid bacteria has ventured into the cosmetics market with products made from fermented ingredients utilizing its proprietary lactic acid bacteria.

Expanding Nutraceutical Industry

The expanding nutraceutical industry is driving the global lactobacillus probiotic market. As the nutraceutical sector grows, driven by increasing consumer demand for health-enhancing products, the market for lactobacillus probiotics is experiencing significant growth. Nutraceuticals, which encompass dietary supplements, functional foods, and beverEnd-Users, often incorporate probiotics to enhance their health benefits, thereby boosting the market demand for lactobacillus strains.

The market is seeing increased collaborations between nutraceutical companies and scientific research institutions. These partnerships aim to validate the health claims of lactobacillus probiotics, enhancing product credibility and consumer trust. As a result, the market is characterized by a steady influx of scientifically-backed lactobacillus probiotic products that appeal to health-conscious consumers.

For instance, on September 9, 2023, SIG and AnaBio Technologies collaborated to introduce the world's first long-life probiotic yogurt, marking a significant advancement in probiotic beverages and aseptic packaging. This pioneering achievement heralds the emergence of a novel product category: probiotic beverages packaged in aseptic carton packs and spouted pouches, offering extended shelf stability without the need for refrigeration.

Lack of Consumer Awareness in Developing Regions

Lack of consumer awareness in developing regions is restraining the global lactobacillus probiotic market. In these regions, limited knowledge about the health benefits of probiotics and misconceptions about their use are hindering market growth. Despite the potential health advantages of lactobacillus probiotics, the market is facing challenges in reaching and educating consumers in developing areas.

Consumers in developing regions are less likely to seek out or trust these products, often prioritizing more traditional or familiar health solutions. Consequently, market penetration for lactobacillus probiotics remains limited, impacting overall market growth. Market players are encountering difficulties in marketing and distribution. Without a well-informed consumer base, efforts to promote lactobacillus probiotic products face significant obstacles.

Segment Analysis

The global lactobacillus probiotic market is segmented based on form, distribution channel, application, end-user and region.

Increasing Consumer Focus on Health and Wellness

The dietary supplements segment holds the largest share of the global lactobacillus probiotic market. In an era where individuals are increasingly prioritizing their health and wellness, dietary supplements, particularly those containing lactobacillus probiotics, have become a popular choice. These supplements are widely recognized for their benefits in supporting digestive health, enhancing immune function, and maintaining overall wellness, propelling the dietary supplements segment to the forefront of the lactobacillus probiotic market.

Market innovations are also playing a critical role in the dominance of the dietary supplements segment. Companies within the probiotic industry are continuously investing in research and development to create advanced and more effective probiotic formulations. These innovations include the development of multi-strain probiotic supplements, time-release capsules, and targeted delivery systems that enhance the efficacy and stability of lactobacillus probiotics.

Geographical Penetration

Growing Health-conscious Consumer Base and Innovations in Asia-Pacific

Asia-Pacific is positioned to dominate the global lactobacillus probiotic market. The Asia-Pacific region has a long history of consuming fermented foods, which naturally contain probiotics. This cultural familiarity with probiotics makes it easier for consumers to embrace lactobacillus probiotic supplements and functional foods, propelling the lactobacillus probiotic market growth.

Consumers are proactively seeking products that support long-term health and wellness, leading to a surge in demand for lactobacillus probiotics as part of a preventive health regimen. The market in Asia-Pacific is characterized by significant investments in research and development. Companies are innovating with new formulations and delivery methods, such as probiotic beverages, snacks, and supplements, tailored to local tastes and preferences, enhancing market appeal.

COVID-19 Impact Analysis

The market experienced supply chain disruptions due to lockdowns and restrictions. These disruptions affected the production and distribution of lactobacillus probiotic products, leading to temporary short-end users and delays in product availability. However, with the focus on preventive health rising during the pandemic, the market has seen a surge in demand for functional foods and beverages. Products containing lactobacillus probiotics have become popular as consumers look for ways to enhance their health through diet.

The pandemic accelerated the shift to online retail as consumers avoided physical stores. The market saw a significant increase in the sale of lactobacillus probiotic products through e-commerce platforms, which provided a convenient and safe way for consumers to purchase health supplements. Companies have developed new formulations and delivery formats for lactobacillus probiotics, to cater to the growing health-conscious consumer base.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has significantly impacted the global lactobacillus probiotic market through a series of complex and interrelated factors. The most prominent effect has been on supply chain disruptions. Both Russia and Ukraine are crucial players in the global agricultural market, providing essential raw materials used in the production of lactobacillus probiotics. The conflict has led to severe interruptions in the supply of these raw materials, which has in turn affected the manufacturing processes of probiotic producers.

Market demand has also experienced fluctuations due to the economic instability triggered by the war. Consumer spending patterns have shifted, with many individuals prioritizing essential goods over discretionary items like health supplements. This change in consumer behavior has led to a potential decline in demand for lactobacillus probiotics in regions heavily affected by the conflict.

By Form

  • Liquid
  • Powder
  • Capsule
  • Tablet
  • Others

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarkets and Hypermarkets
  • Online Pharmacy
  • Others

By Application

  • Food and Beverage
  • Drugs
  • Dietary Supplements
  • Others

By End-User

  • Infants
  • Children
  • Adults
  • Seniors

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On April 27, 2023, Gnosis by Lesaffre expanded its probiotic lineup with the introduction of LifeinU L. rhamnosus GG 350, a new quality specification of their well-established probiotic strain LifeinU L. rhamnosus GG. Lactobacillus rhamnosus GG is widely utilized in various products around the world to promote digestive health.
  • On February 11, 2022, Indian scientists launched a breakthrough in probiotic research, introducing a next-generation probiotic with promising implications for longevity and healthy aging. The probiotic bacterium, Lactobacillus Plantarum JBC5, represents a significant discovery in the quest for beneficial bacteria to enhance well-being, particularly in fermented dairy products.
  • On February 26, 2021, Sweet Cures, a globally recognized manufacturer and retailer of natural health food supplements, introduced an innovative line of probiotics, featuring up to 17 live strains of bacteria supported by clinical research. Expanding on the popularity of Sweet Cures Probiotic Blend Capsules, the company has partnered with industry leader Danisco to develop the new UniBac range.

Competitive Landscape

The major global players in the lactobacillus probiotic market include Mitushi BioPharma, Goerlich Pharma GmbH, Nutra Healthcare Private Limited, Fermentis Life Sciences, Unique Biotech, Culturelle Probiotic Canada, BJP Laboratories, ProbioFerm, Fido Pharma Pvt. Ltd., and Probiotics Australia.

Why Purchase the Report?

  • To visualize the global lactobacillus probiotic market segmentation based on form, distribution channel, application, end-user and region, as well as understand critical commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous global lactobacillus probiotic market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of critical products of all the major players.

The global lactobacillus probiotic market report would provide approximately 70 tables, 68 figures, and 213 users.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Form
  • 3.2. Snippet by Distribution Channel
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Awareness about the Health Benefits of Probiotics
      • 4.1.1.2. Expanding Nutraceutical Industry
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Consumer Awareness in Developing Regions
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Liquid*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Powder
  • 7.4. Capsule
  • 7.5. Tablet
  • 7.6. Others

8. By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 8.1.2. Market Attractiveness Index, By Distribution Channel
  • 8.2. Retail Pharmacy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hospital Pharmacy
  • 8.4. Supermarkets and Hypermarkets
  • 8.5. Online Pharmacy
  • 8.6. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Food and Bever End-User*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Drugs
  • 9.4. Dietary Supplements
  • 9.5. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Infants*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Children
  • 10.4. Adults
  • 10.5. Seniors

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Russia
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Mitushi BioPharma*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Goerlich Pharma GmbH
  • 13.3. Nutra Healthcare Private Limited
  • 13.4. Fermentis Life Sciences
  • 13.5. Unique Biotech
  • 13.6. Culturelle Probiotic Canada
  • 13.7. BJP Laboratories
  • 13.8. ProbioFerm
  • 13.9. Fido Pharma Pvt. Ltd.
  • 13.10. Probiotics Australia

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us